Predictive analysis of breast cancer response to neoadjuvant chemotherapy through plasma metabolomics.

Miki YamadaHiromitsu JinnoSaki NaruseYuka IsonoYuka MaedaAyana SatoAkiko MatsumotoTatsuhiko IkedaMasahiro Sugimoto

Published in: Breast cancer research and treatment (2024)

The application of plasma metabolomics, utilizing CE-MS and LC-MS, may serve as a tool for predicting the efficacy of neoadjuvant chemotherapy in breast cancer in the future after all necessary validations have been completed.

Keyphrases

neoadjuvant chemotherapy
mass spectrometry
locally advanced
lymph node
sentinel lymph node
multiple sclerosis
rectal cancer
ms ms
squamous cell carcinoma
current status
young adults